There is no universal number, and that is the honest answer.
GHK-Cu dosage is not a fixed figure you can look up and copy, and anyone presenting it that way is guessing on your behalf. Dosing depends on the route, the concentration a pharmacy compounds, how often the preparation is used, how long it is used for, and how your skin or system responds along the way. This page explains how a licensed clinician reasons through those variables. It deliberately does not contain dose numbers or a chart. For the full background on the peptide itself, read our GHK-Cu peptide guide, and to see where copper peptides sit alongside other protocols, see our longevity and peptide therapy page. GHK-Cu is not FDA-approved, and prescription approval is never guaranteed.
Search for GHK-Cu peptide injection dosage and you will find charts on forums, marketplaces, and research chemical sites. None of them know your health history, none of them are accountable if something goes wrong, and most of them are extrapolated from animal work or copied from each other. A responsible clinic does not publish a public number that a stranger could self-administer from, because the number is the least important part of the decision. The assessment is the important part. Human evidence for GHK-Cu is limited and much of it is preclinical or small-scale, which is another reason a confident-looking chart is misleading. If GHK-Cu is clinically appropriate for you, a licensed US clinician sets the strength, the frequency, and the duration for your prescription specifically, and adjusts it after reviewing your response.
It would be easy to publish a chart and collect the traffic. It would also be careless. The people most likely to copy a dose off a web page are the people with the least support if it goes badly. If you want a real answer for your situation, start with our longevity and peptide therapy consultation and let a licensed clinician give you one.
There is no single standard. Dosage depends on the route, the compounded concentration, the frequency, and your individual tolerance. A licensed clinician sets it after an assessment, and adjusts it based on how you respond.
Because a public chart invites unsupervised injection by people the clinic has never assessed. Injectable route, strength, and site are prescriber-directed decisions. If you want the difference between the routes explained, read our GHK-Cu peptide injection page.
Yes. Topical preparations are described by peptide concentration in a base and application frequency, while injectable use is a clinician-directed decision with far less human evidence behind it. Our topical GHK-Cu page covers the topical side in depth.
Skin research on copper peptides is measured in weeks to months, so meaningful review usually happens after a period of consistent use rather than after a few days. Your provider sets the review point.
No. Escalating on your own increases irritation risk without evidence that more is better, and it removes the clinician from a decision they are responsible for. Report back instead and let your provider adjust.
No. GHK-Cu is not FDA-approved for any use, and compounded preparations are not FDA-approved. Nothing here is intended to diagnose, treat, cure, or prevent any disease.
GHK-Cu is not FDA-approved. This page does not provide dosing instructions and is not a substitute for medical advice. Compounded GHK-Cu preparations are prepared by US state-licensed pharmacies and are not FDA-approved. Prescription products require an online consultation with a licensed US clinician where clinically appropriate; approval is not guaranteed. Human research on GHK-Cu is limited and much of it is preclinical or small-scale. Statements on this page have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary.
Start your free consultation right now
No clinic visit. Licensed US clinicians. Dispatched within 24 hours of your consultation and payment.